Heart failure: a growing public health problem

Area of Science:

• Cardiology
• Public Health
• Geriatrics

Background:

• Heart failure (HF) mortality is rising, contrasting with declining coronary heart disease and stroke deaths.
• HF is a significant financial burden, with approximately one-third of patients hospitalized annually.
• HF prevalence and incidence increase sharply with age, affecting nearly 10% of individuals over 80.

Purpose of the Study:

• To review the scope of heart failure as an escalating public health issue.
• To examine the causes, risk factors, and current treatment strategies for heart failure.
• To highlight the potential benefits of early intervention and preventative measures.

Main Methods:

• Literature review of large-scale studies on heart failure prevalence, incidence, and treatment.
• Analysis of the impact of ACE inhibitors on heart failure outcomes.
• Examination of public health and economic implications of heart failure management.

Main Results:

• Angiotensin-converting enzyme (ACE) inhibitors have demonstrated efficacy in reducing heart failure mortality, preventing disease development, and decreasing hospitalizations.
• Effective management strategies can lead to significant economic benefits for public health systems.
• Preventing underlying causes and risk factors for heart failure offers the most substantial long-term benefits.

Conclusions:

• Heart failure represents a growing public health challenge requiring urgent attention.
• Early recognition and timely, adequate treatment, particularly with ACE inhibitors, are crucial for improving prognosis and reducing healthcare burdens.
• Preventative strategies targeting underlying causes and risk factors are paramount for long-term population health and economic well-being.